Jonas A. de Souza

Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)

Jonas A. de Souza, Bonnie J. Yap, Kristen Wroblewski et al. · Cancer · 2016 · 819 citations · Full text

Quality Of Life, Cancer Management, Clinical Endpoint +17

The development of a financial toxicity patient‐reported outcome in cancer: The COST measure

Jonas A. de Souza, Bonnie J. Yap, Fay J. Hlubocky et al. · Cancer · 2014 · 607 citations · Full text

Thyroid Cancer: Burden of Illness and Management of Disease

Rebecca Brown, Jonas A. de Souza, Ezra E.W. Cohen · Journal of Cancer · 2011 · 187 citations · Full text

Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor–Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial

Maria E. Cabanillas, Jonas A. de Souza, Susan M. Geyer et al. · Journal of Clinical Oncology · 2017 · 128 citations · Full text

Oral Multikinase Inhibitors, Oncology, Medicine +15

A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Jonas A. de Souza, Darren W. Davis, Yujian Zhang et al. · Clinical Cancer Research · 2012 · 113 citations · Full text